Cardiac troponin levels serve as a pivotal parameter in the evaluation and understanding of cardiac health. These troponins, specific proteins located in cardiac muscle cells, act as valuable biomarkers that can signify myocardial injury. The release of troponins into the bloodstream becomes particularly relevant in scenarios such as heart attacks or other cardiac events. A surge in troponin levels corresponds to damage to the heart muscle, providing healthcare professionals with a reliable diagnostic indicator. The advancements in high sensitivity troponin assays have remarkably increased the precision of detecting even minor cardiac injuries, allowing for prompt intervention and enhancing overall patient outcomes. Beyond the acute phase, continuous monitoring of troponin levels proves beneficial in assessing the progression of heart damage and guiding ongoing treatment plans. In the evolving landscape of cardiology, the measurement of cardiac troponin levels stands as an indispensable tool, contributing significantly to improved patient care and the advancement of cardiac science.
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, Tianjin University, China
Title : Not So Idiopathic After All: Genotype, Phenotype and IL-1 Blockade Response Converge in Recurrent Pericarditis
burcu yagmur, Kyrenia University Hospital, Cyprus
Title : Beyond the Heart in Cardiovascular Magnetic Resonance Imaging: Prevalence and Clinical Significance of Incidental Extracardiac Findings
burcu yagmur, Kyrenia University Hospital, Cyprus
Title : Cardiovascular mortality in colon cancer a patient characteristics analysis: Population-based study
Nouf, KAU, Saudi Arabia
Title : Improving Screening and Treatment of Iron Deficiency in Patients with Heart Failure with Reduced Ejection Fraction: A Two-Cycle Quality Improvement Project
Danish Malik, University Hospitals Dorset NHS Foundation Trust, United Kingdom